Serial 97489630
Live / Registered — Registered (as of 21 May 2024)
What this means for you
Registered since 21 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97489630
- Registration number
- 7390296
- Mark type
- Design / logo
- Filed
- 05 Jul 2022
- Published for opposition
- 05 Mar 2024
- Registered
- 21 May 2024
- Attorney of record
- Loren R. Hulse
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of anti-cancer drugs
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Anti-cancer preparations of chemical origin; Anti-cancer preparations from hormones and antagonists; Anti-cancer preparations of microbial origin; Anti-cancer preparations of plant origin; Compounds for treating cancer; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Medical preparations for the treatment of cancer; Chemical preparations for medical purposes for the treatment of cancer; Biochemical preparations for medical use for the treatment of cancer; Biological preparations for medical purposes for the treatment of cancer; Anti-cancer drugs; Antitumor drugs; Injectable pharmaceuticals for the treatment of cancer; Medicinal preparations and substances for the treatment of cancer; Medicines for human purposes for the treatment of cancer; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical compositions for the treatment of cancer; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for human use for the treatment of cancer; Pharmaceutical preparations for treating gastrointestinal disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceuticals for the treatment of cancer; Tumor suppressing agents; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for suppressing tumors; Compounds for treating resistant cancers; Pharmaceutical preparations and substances for the treatment of treatment-resistant cancers
- Class 042 — Scientific and technological services: Scientific research for medical purposes in the area of cancerous diseases; Medical research in the field of oncology
Owner
- Scandion Oncology A/S, København Ø, DK
- Scandion Oncology A/S, København Ø, DK
- Scandion Oncology A/S, København Ø, DK
Prosecution history
- 21 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Mar 2024 — PUBLISHED FOR OPPOSITION
- 14 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jan 2024 — ELECTRONIC RECORD REVIEW COMPLETE
- 19 Jan 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 16 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jan 2024 — EXAMINER'S AMENDMENT ENTERED
- 16 Jan 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 16 Jan 2024 — EXAMINERS AMENDMENT E-MAILED
- 16 Jan 2024 — EXAMINERS AMENDMENT -WRITTEN
- 30 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE